XML 25 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
7 Months Ended 9 Months Ended 10 Months Ended
Sep. 30, 2022
Sep. 30, 2023
Dec. 31, 2022
Cash Flows from Operating Activities:      
Net income (loss) $ (2,847) $ 1,729,250 $ (8,687)
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Interest income on investments held in Trust Account (3,604,815)  
Change in fair value of Forward Purchase Agreement 80,000  
Changes in operating assets and liabilities:      
Prepaid expenses (2,882) (152,989) (1,372)
Accounts payable 354,495  
Accrued expenses 59,270  
Accrued expenses – related party 10,000  
Income tax payable 757,011  
Net cash used in operating activities (5,729) (767,778) (10,059)
Cash Flows from Investing Activities:      
Investment of cash in Trust Account (117,875,000)  
Net cash used in investing activities (117,875,000)  
Cash Flows from Financing Activities:      
Proceeds from issuance of Class B ordinary shares to Sponsor 25,000   25,000
Proceeds from promissory note – related party 300,000   300,000
Advance from Sponsor for payment of formation costs 412   412
Repayment to Sponsor for payment of formation costs (412)   (412)
Proceeds from sale of Placement Units 5,653,750  
Proceeds from sale of Units, net of underwriting discount paid 113,735,000  
Proceeds from stock subscriptions received 206  
Repayment of Promissory note – related party (300,000)  
Payment of offering costs (112,351) (466,173) (226,664)
Net cash provided by financing activities 212,649 118,622,783 98,336
Net Change in Cash 206,920 (19,995) 88,277
Cash – Beginning of period 88,277
Cash – End of period 206,920 68,282 88,277
Non-cash investing and financing activities:      
Initial measurement of forward purchase options liabilities 8,810,000  
Accretion of Class A ordinary shares subject to redemption value 14,419,398  
Valuation of Representative Shares 132,480  
Offering costs included in Accrued offering costs 92,094 70,000 142,138
Deferred underwriting fee payable $ 3,450,000  
Issuance of Class B ordinary shares to Sponsor for subscription receivable     $ 206